ATE116312T1 - Antimigräne alkoxypyrimidinderivate. - Google Patents

Antimigräne alkoxypyrimidinderivate.

Info

Publication number
ATE116312T1
ATE116312T1 AT91110376T AT91110376T ATE116312T1 AT E116312 T1 ATE116312 T1 AT E116312T1 AT 91110376 T AT91110376 T AT 91110376T AT 91110376 T AT91110376 T AT 91110376T AT E116312 T1 ATE116312 T1 AT E116312T1
Authority
AT
Austria
Prior art keywords
antimigraine
alkoxypyrimidine
derivatives
alkoxypyrimidine derivatives
indolylalkyl
Prior art date
Application number
AT91110376T
Other languages
English (en)
Inventor
David W Smith
Frank D Yocca
Joseph P Yevich
Ronald J Mattson
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE116312T1 publication Critical patent/ATE116312T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
AT91110376T 1990-06-29 1991-06-24 Antimigräne alkoxypyrimidinderivate. ATE116312T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54612290A 1990-06-29 1990-06-29
US68020891A 1991-04-04 1991-04-04
SG15595A SG15595G (en) 1990-06-29 1995-01-30 Antimigraine alkoxypyrimidine derivatives

Publications (1)

Publication Number Publication Date
ATE116312T1 true ATE116312T1 (de) 1995-01-15

Family

ID=27356028

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91110376T ATE116312T1 (de) 1990-06-29 1991-06-24 Antimigräne alkoxypyrimidinderivate.

Country Status (15)

Country Link
US (1) US5300506A (de)
EP (1) EP0464558B1 (de)
JP (1) JPH04230378A (de)
AT (1) ATE116312T1 (de)
AU (1) AU643038B2 (de)
CA (1) CA2043709C (de)
CY (1) CY1831A (de)
DE (1) DE69106237T2 (de)
DK (1) DK0464558T3 (de)
ES (1) ES2066278T3 (de)
FI (1) FI101224B (de)
HK (1) HK51995A (de)
IE (1) IE66687B1 (de)
PT (1) PT98115B (de)
SG (1) SG15595G (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077293A (en) * 1990-06-29 1991-12-31 Bristol-Myers Squibb Co. 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines
CA2084531A1 (en) * 1991-12-19 1993-06-20 David W. Smith Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
GB9226610D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
US5521188A (en) * 1993-09-16 1996-05-28 Bristol-Myers Squibb Company Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
CA2130078A1 (en) * 1993-09-16 1995-03-17 Jonas A. Gylys Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
ES2079323B1 (es) * 1994-06-21 1996-10-16 Vita Invest Sa Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes.
US5550239A (en) * 1994-11-08 1996-08-27 Bristol-Myers Squibb Company Process for large-scale production of indolyl alkyl pyrimidinyl piperazine compounds
GB9423682D0 (en) * 1994-11-23 1995-01-11 Merck Sharp & Dohme Therapeutic agents
GB9501865D0 (en) * 1995-01-31 1995-03-22 Merck Sharp & Dohme Therapeutic agents
US5618816A (en) * 1995-03-02 1997-04-08 Bristol-Myers Squibb Company Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines
WO1997000244A1 (en) * 1995-06-19 1997-01-03 Eli Lilly And Company Process for parallel synthesis of a non-peptide library
AU707750B2 (en) * 1995-08-07 1999-07-22 Merck Sharp & Dohme Limited Substituted 1-indolylpropyl-4-phenethylpiperazine derivatives
JPH09124643A (ja) * 1995-08-14 1997-05-13 Bristol Myers Squibb Co 抗うつ作用を有する1−アリールアルキル−4−(アルコキシピリジニル)−又は4−(アルコキシピリミジニル)ピペラジン誘導体
AR004229A1 (es) * 1995-11-06 1998-11-04 Wyeth Corp Derivados indolalquilo de benzodioxanmetilamina y su uso para preparar medicamentos
GB9609374D0 (en) * 1996-05-03 1996-07-10 Merck Sharp & Dohme Therapeutic agents
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
FR2799463B1 (fr) * 1999-10-12 2004-04-16 Adir Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent
WO2002079153A1 (en) * 2001-03-28 2002-10-10 Biocatalytics, Inc. Method for producing tryptamine derivatives
US6800637B2 (en) 2002-09-12 2004-10-05 Wyeth Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
EP1632491A1 (de) * 2004-08-30 2006-03-08 Laboratorios Del Dr. Esteve, S.A. Substituierte indol-verbindungen und deren verwendung als modulatoren des 5-ht6 rezeptors
US20080103312A1 (en) * 2006-08-29 2008-05-01 Kansal Vinod K Processes for the synthesis of 5-phenyl-1-trityl-1H-tetrazole
EP2036888A1 (de) * 2007-09-17 2009-03-18 Laboratorios del Dr. Esteve S.A. Naphthyl-substituierte Sulfonamide
JP2011517440A (ja) * 2008-03-14 2011-06-09 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 中枢神経系障害を処置するためのアザインドール化合物
US20090281114A1 (en) * 2008-05-08 2009-11-12 Fabre-Kramer Pharmaceuticals, Inc. Indolylalkyl derivatives of pyrimidinylpiperazine and metabolites thereof for treatment of anxiety, depression, and sexual dysfunction
WO2015014256A1 (en) 2013-07-29 2015-02-05 Sunshine Lake Pharma Co., Ltd. Substituted heteroaryl compounds and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB944443A (de) * 1959-09-25 1900-01-01
GB1189064A (en) * 1967-05-01 1970-04-22 Sterling Drug Inc Indole Derivatives
NL7103002A (de) * 1970-03-06 1971-09-08
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8601959D0 (en) * 1986-01-28 1986-03-05 Glaxo Group Ltd Indole derivatives
US4954502A (en) * 1988-06-10 1990-09-04 Bristol-Myers Squibb Company 1-indolyalkyl-4-(substituted-pyridinyl)piperazines
FR2635104B1 (fr) * 1988-08-03 1992-04-30 Synthelabo Derives d'indolone, leur preparation et leur application en therapeutique
US5077293A (en) * 1990-06-29 1991-12-31 Bristol-Myers Squibb Co. 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines

Also Published As

Publication number Publication date
JPH04230378A (ja) 1992-08-19
FI101224B1 (fi) 1998-05-15
DK0464558T3 (da) 1995-03-13
PT98115B (pt) 1998-12-31
ES2066278T3 (es) 1995-03-01
IE66687B1 (en) 1996-01-24
HK51995A (en) 1995-04-13
CY1831A (en) 1995-12-01
US5300506A (en) 1994-04-05
SG15595G (en) 1995-06-16
DE69106237D1 (de) 1995-02-09
EP0464558A1 (de) 1992-01-08
IE912280A1 (en) 1992-01-01
FI913142A0 (fi) 1991-06-27
FI101224B (fi) 1998-05-15
CA2043709C (en) 2002-01-22
FI913142L (fi) 1991-12-30
DE69106237T2 (de) 1995-05-11
AU643038B2 (en) 1993-11-04
EP0464558B1 (de) 1994-12-28
PT98115A (pt) 1992-03-31
CA2043709A1 (en) 1991-12-30
AU7941691A (en) 1992-01-02

Similar Documents

Publication Publication Date Title
ATE116312T1 (de) Antimigräne alkoxypyrimidinderivate.
DE69433802D1 (de) Therapeutisch wirksame linksdrehende und rechtsdrehende 1-((4-Chlorphenyl)phenylmethyl) Piperazine
MY103352A (en) Piperazinyl-heterocyclic compounds
FI891716A7 (fi) HIV-proteaasi-inhibiittoreita, jotka ovat käyttökelpoisia AIDS'in hoidossa
DK0646115T3 (da) Heterocykliske/cykliske aminderivater
FI981591L (fi) AIDS:n hoidossa käyttökelpoisia HIV-proteaasi-inhibiittoreita
NO990542L (no) K-252a-derivater og anvendelse av K-252a-derivater
DE69623899D1 (de) Behandlung von Tinnitus mit neuroprotektiven Wirkstoffen
FI911980A0 (fi) N-(3-fluor-2-fosfonylmetoxipropyl) -derivat av heterocykliska purin- och pyrimidinbaser, deras framstaellning och anvaendning.
EP0276536A3 (en) Use of buspirone for the improvement of short term memory
DE59107445D1 (de) Kombination von Arbeitsgerät und höhenverstellbare Versorgungseinheit
ATE122232T1 (de) Melatoninderivate und kombinationen mit antiestrogenen zur behandlung von brustkarzinoma.
ATE133663T1 (de) Antiglancoma-zusammensetzungen enthaltend 3- arylcarbonyl-1-aminoalkyl-1h-indol
DE68923860D1 (de) Derivate von Alkoholen und Ethern.
DE69106388D1 (de) Antipsychotische 4-(1,2-benzisoazolyl)piperidinderivate.
DE3876846D1 (de) Morpholinderivate und deren verwendung.
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
DE69112192D1 (de) Antiherpes-Castanosperminester.
GR3015716T3 (en) Use of buspirone in sleep apneas.
ATE70181T1 (de) Verwendung von oxochinazolinderivaten bei der behandlung von hyperurikaemie.
DE58909244D1 (de) Verwendung von 1,4-Dihydropyridin-Derivaten in der Behandlung von Alkoholsucht.
DK0457324T3 (da) Heterocycliske NMDA antagonister
DK0661058T3 (da) Anvendelse af bradykininantagonister til behandling af virussygdomme
DE69107214D1 (de) Laser und verstärker.
ATE90565T1 (de) Behandlung des schocks mit cyclodextrin und dessen derivaten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee